In conclusion, our study provides insight into the clinical significance of PSPH in NSCLC and demonstrates that PSPH activates the AKT/AMPK signaling pathway, leading to enhanced NSCLC cell proliferation, migration, and invasion. This evidence concerns the gene AKT1 and non-small cell lung carcinoma.